Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RAPPRAPP
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in RAPPORT THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 2.9M shares of RAPP (RAPPORT THERAPEUTICS INC), worth $121.3M as of 2026-Q2. The position was decreased (-1.1% shares). RAPP represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$121.3M

Current Shares

2.9M

Total Value Change

+$99.1M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.9M
-1.1%
$121.3M0.0%$41.67
0
2026-Q1
Decreased
2.9M
-2.0%
$92.1M0.0%$27.85
0
2025-Q4
Increased
3M
+23.9%
$91.1M0.0%$30.64
36
2025-Q3
Increased
2.4M
+96.1%
$71.9M0.0%$27.97
47
2025-Q2
Decreased
1.2M
-0.8%
$14M0.0%$11.43
0
2025-Q1
Decreased
1.2M
-0.6%
$12.5M0.0%$10.05
0
2024-Q4
New
1.3M
-
$22.2M0.0%$18.49
39

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used